Do you want to read an article? Please log in or register.
Roxadustat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome: Open-label, Dose-selection, Lead-in Stage of a Phase 3 Study
Non-Malignant Blood Disorders